首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >High Prevalence of KatG Ser315Thr Substitution among Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Northwestern Russia 1996 to 2001
【2h】

High Prevalence of KatG Ser315Thr Substitution among Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Northwestern Russia 1996 to 2001

机译:1996年至2001年俄罗斯西北地区耐异烟肼结核分枝杆菌临床分离株中KatG Ser315Thr替代的高发生率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A total of 204 isoniazid (INH)-resistant strains of Mycobacterium tuberculosis isolated from different patients in the northwestern region of Russia from 1996 to 2001 were screened by a PCR-restriction fragment length polymorphism (RFLP) assay. This assay uses HapII cleavage of an amplified fragment of the katG gene to detect the transversion 315AGC→ACC (Ser→Thr), which is associated with INH resistance. This analysis revealed a 93.6% prevalence of the katG S315T mutation in strains from patients with both newly and previously diagnosed cases of tuberculosis (TB). This mutation was not found in any of 57 INH-susceptible isolates included in the study. The specificity of the assay was 100%; all isolates that contained the S315T mutation were classified as resistant by a culture-based susceptibility testing method. The Beijing genotype, defined by IS6110-RFLP analysis and the spacer oligonucleotide typing (spoligotyping) method, was found in 60.3% of the INH-resistant strains studied. The katG S315T shift was more prevalent among Beijing genotype strains than among non-Beijing genotype strains: 97.8 versus 84.6%, respectively, for all isolates, including those from patients with new and previously diagnosed cases, isolated from 1999 to 2001 and 100.0 versus 86.5%, respectively, for isolates from patients with new cases isolated from 1996 to 2001. The design of this PCR-RFLP assay allows the rapid and unambiguous identification of the katG 315ACC mutant allele. The simplicity of the assay permits its implementation into routine practice in clinical microbiology laboratories in regions with a high incidence of TB where this mutation is predominant, including northwestern Russia.
机译:通过PCR-限制性片段长度多态性(RFLP)分析筛选了1996年至2001年从俄罗斯西北地区不同患者分离出的204株耐异烟肼(INH)结核分枝杆菌菌株。该测定法使用katG基因的扩增片段的HapII切割来检测与INH抗性相关的转化315AGC→ACC(Ser→Thr)。这项分析显示,新近和先前诊断出的结核病(TB)患者的菌株中,katG S315T突变的患病率为93.6%。在研究中包括的57种INH易感菌株中均未发现此突变。该测定的特异性为100%。通过基于培养物的敏感性测试方法,所有包含S315T突变的菌株都被归类为抗药性。通过IS6110-RFLP分析和间隔区寡核苷酸分型(spoligotyping)方法定义的北京基因型,在60.3%的INH耐药菌株中发现。 katG S315T转移在北京基因型菌株中比在非北京基因型菌株中更为普遍:所有分离株的分离率分别为97.8%和84.6%,包括从1999年至2001年分离的新诊断和先前诊断病例的分离株以及100.0 vs 86.5分离的菌株从1996年至2001年新病例中分离出的分离物分别为5%。此PCR-RFLP分析的设计可快速,明确地鉴定katG 315ACC突变体等位基因。该方法的简便性使其可在结核病高发地区(主要是俄罗斯西北部)的结核病高发地区的临床微生物实验室中进行常规操作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号